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*e binding interaction between bovine serum albumin (BSA) and sodium salt of risedronic acid (RSN) was studied by using the
FT-IR (Fourier transform infrared), UV-Vis (ultraviolet–visible), ﬂuorescence (emission and synchronous), CD (circular di-
chroism) spectrometric, and computational (molecular docking) techniques at 289, 297, and 305K temperatures with physi-
ological buﬀer of pH 7.40. *e conformational and secondary structural changes observed for BSA from CD spectra and by curve
ﬁtting procedure were applied to Fourier self-deconvolution in FT-IR spectra. *e formation of a BSA-RSN complex was
conﬁrmed from UV-Vis spectroscopy. *e static type of quenching shown for RSN to BSA was veriﬁed from Stern–Volmer and
modiﬁed Stern–Volmer equations. *e binding constant of order 105 was obtained to be conﬁrming that there exists a strong
binding interaction between BSA and RSN. Synchronous ﬂuorescence shows that the microenvironment of tryptophan was
altered, not tyrosine of BSA; in addition to this, the distance between tryptophan of BSA and RSN was found out from Forster’s
theory of nonradiation energy transfer. *e interaction between BSA and RSNmainly occurred as a result of hydrogen bonds and
van der Waals forces, the process is exothermic and spontaneous, and it was achieved through van ’t Hoﬀ equation. *is
interaction was aﬀected by the presence of biologically active Fe2+, Ni2+, Ca2+, Mg2+, and Cd2+ ions and was also studied. *e
subdomain IIIA of BSA involved with RSN interaction was authenticated from molecular docking analysis.
1. Introduction
*e very most familiar problem arising in the old age of
human beings is osteoporosis and Paget’s disease [1, 2].
Osteoporosis is the disease that causes breaking of the bone
when the bone’s weakness increases. *is disease mainly
aﬀects women compared with men. In 2010 survey, about 22
million women and 5.5 million men in European Union, 8
million women and 1 million men in United states, and
Asian people who are at the highest risk were suﬀered from
this disease [3, 4]. Another bone-related issue is Paget’s
disease which aﬀects one or more bones but not complete
skeleton to cellular reshaping and disﬁgurement such as
skull, femur, pelvis, and vertebrae [5]. *is disease, on rare
cases, converts into severe complication called malignant
bone cancer. About 1.5 to 8.0% of British descent [6] have
Paget’s disease.*e ratio of Paget’s disease in men to women
is of the order 3 : 2 [7]. *e well-known drug that is used to
treat and prevent osteoporosis and Paget’s disease is sodium
salt of risedronic acid called as risedronate sodium
(Figure 1(a)) which is a bisphosphonate, and its IUPAC name
is sodium hydroxyl-(1-hydroxy-1-phosphono-2-pyridin-3-
ylethyl)phosphinate. *is drug is taken orally as immediate
and delayed release tablet [8]. It has common side eﬀects such
as back pain, heartburn, diarrhea, and indigestion [9].
In recent years, researchers are focusing more on the
interaction between drugs and biomacromolecules [10, 11].
Serum albumin is the most abundant plasma protein present
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in vertebrate blood. It has a major role in transportation,
distribution, and biological process of many endogenous and
exogenous ligands (drugs, fatty acids, pharmaceuticals, etc.) to
exact targets [12]. *e concentration of drug in free and
bound form with serum albumin in the plasma gives in-
formation on the mechanism of action on the desired disease.
*erefore, the rate of evident distribution and elimination of
drugs can be found out with help of protein-drug interaction
studies. *erefore, this study ﬁnds applications in medicinal
science for designing drugs and in pharmaceutical industries
to improve the drug delivery process.
*e present study chooses the bovine serum albumin
(BSA) in substitute of human serum albumin (HSA) because
of 88% resemblance in structure, easy availability and low cost.
*e heart-shaped structure of BSA is shown in Figure 1(b)
where it is composed of 583 amino acids: whole structure is
divided into 3 homologous domains (I, II, and III) and every
domains is again subdivided into A and B, with hydrophobic
packets with two tryptophan (Trp134 and Trp213) and 20 Tyr
(tyrosine) residues. Trp134 and Trp213 are present on the
surface and buried inside the hydrophobic region of BSA [13].
*e biological features of the protein are then well char-
acterized by essential metal ions binding on to it through their
structure and function. In many metalloproteins and enzymes,
the metal ions are bound tightly and loosely, respectively, for
their stabilization or storage [14–16]. Metal ions with the ratio
of charge to ionic radius is called its polarizing power, this is the
main factor for complexing power of the metal ions with the
proteins. *us, the increased interaction between BSA and
metal ions is achieved by their attaining the high density
positive charge in BSA when the polarizibility of metal ions is
increased. Metal choices, coordination numbers, and geome-
tries are the main parameters for metal binding sites in BSA.
Metal coordinates to BSA are usually through carboxylate
(direction of binding is syn lone-pair) group, sulphur groups,
and carbonyl oxygens of the main chain, tyrosine, tryptophan,
asparagine, serine, aspartic, glutamic, threonine, water mole-
cules, and the side chain of imidazole (lone pairs on nitrogen).
Metal ions having unpaired electrons interact more readily
with the nuclei of BSA.*e native charges and conformational
helical dipoles on BSA play an importance role in metal
binding. Soft metals bind to sulphur containing residues of
methionine and cysteine, while the hard metals bind qualita-
tively to hydrophilic amino acid residues shell surrounded by
hydrophobic (carbon containing) groups of large shell, that is,
diﬀerence of high hydrophobicity centers [17–19].
*emetal ions are very essential for all the living systems
where they may aﬀect the binding interaction between se-
rum albumins and drugs.*is was also studied in the current
work. An insight into the biophysical study of the interaction
between BSA and RSN was investigated by employing
several spectroscopies (emission ﬂuorescence, synchronous
ﬂuorescence, FT-IR, CD, and UV-Vis) and molecular
docking methods. Each performed experiment gave char-
acteristic results and their inference is discussed below.
2. Experimental
2.1. Reagents and Preparation of Solutions. Bovine serum albu-
min (BSA: product number A1933-1G, chromatographically
puriﬁed, ≥98%), risedronate sodium (RSN: product number
SML0650-50MG, NMR, ≥97%), ammonium iron (II) sulfate
hexahydrate (Fe2+: product number 203505-5G, trace metal
basis, 99.997%), ammonium nickel (II) sulfate (Ni2+: product
number 574988-25G, trace metal basis, 99.999%), Calcium
carbonate (Ca2+: product number 202932-5G, trace metal
basis, ≥99.995%), magnesium chloride hexahydrate (Mg2+:
product number 255777-5G, trace metal basis, 99.995%),
cadmium sulfate hydrate (Cd2+: product number 202924-5G,
trace metal basis, ≥99.995%), warfarin (product number
A2250-10G, analytical standard), ibuprofen (product number
I4883-1G, GC, ≥98%), and digitoxin (product number
D5878-250MG, HPLC, ≥92%) were obtained from Sigma-
Aldrich (St. Louis, Missouri, USA). A Tris buﬀer at pH 7.40
(0.05M Tris and 0.15M NaCl with few drops of HCl) and
double distilled water were used to prepare all the solutions
throughout each experiments. *e stock solution of BSA at
concentration of 1.0 × 10−4 mol·L−1 was prepared. RSN,
warfarin, ibuprofen, digitoxin, and metal ion (Fe2+, Ni2+, Ca2+,
Mg2+, and Cd2+) solutions were prepared as a stock at con-
centration of 1.0 × 10−3mol·L−1. For UV-visible, emission
ﬂuorescence, and synchronous ﬂuorescence spectroscopic
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Figure 1: Discovery studio visualization of (a) 3D structure of RSN and (b) secondary structure of BSA. Each site is marked with diﬀerent colour.
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measurements, the concentration of BSA was kept constant
(2.5 × 10−6 mol·L−1) by varying the concentrations of RSN
from 0.5 to 5.5 (×10−6 mol·L−1) by an increment of
0.5 × 10−6 mol·L−1. All the instrumental spectra were corrected
for buﬀer background.
2.2. Methods and Instruments
2.2.1. UV-Visible Spectroscopy. UV-visible absorption spec-
tra in the wavelength range of 200 to 300 nm at 297K (pH
7.40) were taken using the UV-visible spectrophotometer
(Beckman Coulter, DU 730, Life Sciences, Brea, CA 92821,
USA). *is instrument was equipped with deuterium and
tungsten lamps for UV and visible light, respectively. Quartz
cuvettes were used with the path lengths of 10 mm.
2.2.2. Fluorescence Spectroscopy
(1) Instrument. All the ﬂuorescence spectral measurements
were carried out on ﬂuorescence spectrophotometer (F-4600,
HitachiModel, Tokyo, Japan) with 150WXenon lamp and the
excitation and emission slits were kept at 10 nm.
(2) Inner Filter Eﬀect. *e molecule undergoing reabsorption
of radiation emitted results in a noticeable reduction of
emission quantum yield at a particular wavelength (emission or
excitation) is called inner ﬁlter eﬀect. *e excitation (295nm)
and emission (∼340nm) wavelengths of BSA were overlapped
with the absorption spectrum of RSN. *erefore, (1) was
employed to subtract the ﬂuorescence intensity of RSN from all
the BSA ﬂuorescence signals to obtain the desirable ﬂuorescence
signals for BSA:
Fcor � Fobs × e
Aex+Aem( )/2, (1)
where Aex and Aem are the RSN excitation and emission
absorbance of wavelengths, respectively, and Fcor and Fobs
are the corrected and observed ﬂuorescence intensity of BSA,
respectively.
(3) Fluorescence Emission. *e emission ﬂuorescence spectra
were recorded at three diﬀerent temperatures (289, 297, and
305K). *e required temperatures were maintained by using
outer circulating water bath. *e excitation wavelength was set
to 295nm, and emission wavelengths were varied from 290 to
420nm.
(4) Synchronous Fluorescence. By setting the Δλ
(Δλ � λem − λex) at 15 and 60 nm corresponding to Tyr and
Trp of BSA, the synchronous spectral measurements were
achieved. *e wavelength scanned was between 240 and
320 nm at temperature 297K and pH 7.40.
2.2.3. Fluorescence Resonance Energy Transfer (FRET). *e
UV-Vis absorption spectrum and the emission ﬂuorescence
spectrum of RSN and BSA, respectively, with each concen-
tration 3.0 × 10−6 mol·L−1 were recorded in the wavelength
range of 295–425nm. Both the spectra were overlapped and
Forster’s nonradiative energy transfer theory was applied to
calculate the distance between Trp134/Trp213 of BSA and RSN.
2.2.4. Conﬁrmation of Binding Site in the Presence of Site
Markers. Warfarin, ibuprofen, and digitoxin are the three
site markers for sites I, II, and III, respectively, used to study the
competitive binding experiments. Fluorescence experiments of
a BSA-RSN complex in the presence of sitemarkers were carried
out by adjusting the wavelengths at 290–420nm, where the
concentration of BSA and site markers is unchanged by keeping
at 3.0 × 10−6 mol·L−1, and the concentrations of RSN varied
from 0.5 × 10−6 to 5.5 × 10−6 mol·L−1 at 297K and pH 7.40.
2.2.5. Inﬂuence of Fe2+, Ni2+, Ca2+, Mg2+, and Cd2+ Ions on
BSA-RSN Binding. *e eﬀect of Fe2+, Ni2+, Ca2+, Mg2+, and
Cd2+ ions on the binding constant of BSA-RSN system was
analyzed by recording the ﬂuorescence spectra of BSA-RSN
system in the presence of ions by keeping the concentration
of BSA and metal ions constant at 3.0 × 10−6 mol·L−1 with
increasing the concentration of RSN from 0.5 × 10−6 to 5.5 ×
10−6 mol·L−1 in the wavelength range 290–420 nm at 297K
and pH 7.40.
2.2.6. FT-IR Spectroscopy
(1) Instrument. All FT-IR spectral measurements were
carried out on a FT-IR spectrometer (Spectrum Two, Per-
kinElmer, Waltham, MA 02451, USA). *is instrument was
equipped with a beam splitter, detector, and ATR (germa-
nium attenuated total reﬂection) as OptKBr, deuterated-
triglycine sulphate (MIRTGS), and MIRacle Diamond S2PE
accessory, respectively, with about 90 scans and resolution of
4 cm−1.
(2) Change in Conformation of BSA-RSN Interaction. *e
FT-IR spectra were obtained at 297K and pH 7.4 by keeping
the concentration of BSA and RSN same (3.5 × 10−6 mol·L−1).
In addition to buﬀer background, the bound form of BSA with
RSN was taken by correcting the buﬀer+ (RSN-free form)
background.
(3) Alteration of Secondary Structure of BSA by RSN. *e
curve ﬁtting analysis enhanced by second derivative of self-
deconvolution was applied to amide I band (1700–1600 cm−1)
of FT-IR spectra in ORIGINPRO 9.0 64-bit software, where
the overlapped peaks were characterized by single peak each
corresponding to secondary structure of BSA after the in-
teraction of RSN.
2.2.7. Molecular Docking. Protein Data Bank (PDB) was
used to download the crystal structure of BSA with PDB ID:
4F5S (https://www.rcsb.org/structure/4F5S). BSA was fur-
ther subjected to Swiss-Pdb Viewer 4.1.0 software to min-
imize the energy to a very low extent by applying the
GROMOS96 43B1 force ﬁeld. *e structure of risedronate
sodium (RSN) was obtained from PubChem with CID
4194514 (https://pubchem.ncbi.nlm.nih.gov/compound/
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4194514). *e energy minimization of RSN was done by
using Marvin View 5.8.1. Now, the BSA and RSN were ready
for molecular docking determinations. *e software com-
prising Autodock tools, Autogrid 4.2, and Autodock 4.2 was
employed to study the molecular docking for BSA-RSN
binding interactions [20]. Chain B, residual atoms, hetero-
atoms, and water molecules were removed from BSA by
keeping only chain A. *en, polar hydrogens and partial
Kollman charges were added: nonpolar hydrogens were
merged for BSA.*e grid box of dimension 60× 60× 60 along
X, Y, and Z axes with grid spacing 0.375 A˚ was adjusted.*en,
the grid centered coordinates for site I (IIA), site II (IIIA), and
site III (IB) were positioned at (−4.795, 30.487, and 101.007),
(10.906, 16.276, and 119.720), and (19.857, 33.531, and
97.915), respectively, to analyze the molecular docking sep-
arately for each binding sites after interaction of BSA with
RSN. *e docking was run for all the three binding sites
independently by running 90 times. After this process, the
output was estimated using Lamarckian genetic algorithm
(LGA)withmaximumof 2,500,000 energy evaluations, 27,000
generations by assigning random translations, orientations,
and 9 torsions to populations of 150 individuals.*e obtained
results were ﬁgured out by Biovia Discovery Studio 2016.
2.2.8. Circular Dichroism (CD) Spectral Measurements.
J-815 circular dichroism spectropolarimeter (Jasco in-
ternational Co., Ltd., Tokyo, Japan) was used to obtain the
CD spectra of free BSA and bound form of BSA with RSN.
Furthermore, CD spectra were recorded in the region of
200–240 nm at 297K with the cell length, bandwidth, and
scanning speed of about 10mm, 1.00 nm, and 100 nm/min,
respectively. Baseline correction was also performed while
noting down the CD spectra by buﬀer subtraction of pH
7.40.*e ratio of the concentrations of BSA to RSN was kept
at 1 : 20 (3.5 × 10−6 to 70 × 10−6 mol·L−1). *e secondary
structure of BSA before and after interaction with RSN was
found out by using the BeStSel software online server
(bestsel.elte.hu/).
2.2.9. Statistical Analysis and Curve Plotting. All the ex-
periments were measured three times for accuracy, and the
results were expressed in terms of mean ± standard de-
viation (SD). *e acquired results were inspected and data
were evaluated by OriginPro 9.0 64-bit software (OriginLab
Corp., Northampton, MA) and Microsoft Excel.
3. Results and Discussion
3.1. UV-Vis Absorption of BSA with and without RSN.
Change in the conformation of BSA and formation of the
complex after the interaction with RSN is eﬀectively studied
by UV-Vis spectral measurements. *e UV-Vis absorption
spectrum of BSA with diﬀerent concentrations of RSN
(Figure 2) illustrates that the absorption intensity of BSA
increases with increasing the concentration of RSN which
conﬁrms formation of the complex between BSA and RSN.
Additionally, there are two absorption peaks with the red
shifts (3 nm): the stronger one at 220 nm corresponding to
the backbone of the BSA structure, and weaker one at
280 nm corresponding to the π→ π∗ transition for tyrosine
(Tyr), tryptophan (Trp), and Phenylalanine (Phe) residues of
BSA as they belong to aromatic amino acids [21]. From the
above, it concludes that RSN interacted with BSA and also
this interaction aﬀects microenvironment of Tyr, Trp, and
Phe by altering conformation of BSA.
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Figure 2: UV-Vis absorption spectra of BSA (2.5 × 10−6 mol·L−1) with varying concentrations of RSN (0.5 to 5.5 × 10−6 mol·L−1) with the
addition of 0.5 × 10−6 mol·L−1in each step, and the curve L represents RSN only (2.5 × 10−6 mol·L−1) at 297K and pH 7.40.
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3.2. Fluorescence Measurements. Figure 3 shows the ﬂuo-
rescence emission spectra of BSA with the increasing con-
centration of RSN in the solution. It is clearly noticed from
Figure 3 that the intensity of ﬂuorescence for BSA decreases
with increasing RSN concentration indicating that the RSN
binds with BSA. *us, BSA was quenched by RSN. Since the
tyrosine and trypophan are the two aromatic amino acids,
they are responsible for ﬂuorescence emission. In this study,
risedronic acid after interaction with BSA shows two
emission peaks around one for tyrosine and the other for
tryptophan at 308 and 335 nm, respectively, with a slight
blue shift (3 nm) observed for tryptophan not for tyrosine.
*is spectral shift signiﬁes the changes in microenvironment
around tryptophan residues. Notably, the excitation occurs
at 295 nm which is corresponding to tryptophan not for
tyrosine (280 nm). *erefore, only tryptophan was involved
in the interaction [22].
Fluorescence quenching, molecular rearrangements,
excited-state reactions, and energy transfer processes are
consequences of interactions in the molecular level. More-
over, the decease of intensity of the ﬂuorescence is called
ﬂuorescence quenching. *ere are two types of quenching
mechanisms: dynamic and static. *ese two diﬀer by de-
pendence of quenching constant on temperature. *e ground
state complex formation deﬁnes the static quenching; mol-
ecules diﬀusing in the solution deﬁne dynamic quenching,
where the quenching constant increases with the increase in
temperature for dynamic quenching and vice versa for static
quenching. *e conventional Stern–Volmer equation (2) was
used to examine the type of quenching mechanism [23].
F0
F
� 1 + kqτ0[Q] � 1 + KSV[Q], (2)
kq �
KSV
τ0
, (3)
whereF0 andF are the ﬂuorescence intensities of BSA and BSA-
RSN bound form, respectively; [Q] and τ0 (∼5.7 × 10−9s) [24]
are the concentration of RSN and ﬂuorescence lifetime of
biopolymer, respectively; and KSV and kq are the Stern–Volmer
quenching constant and quenching rate constant, respectively.
Figure 4(a) represents the Stern–Volmer plot (F0/F versus [Q]),
which gives the KSV values as slope, and the values kq are
calculated by using (3). *ese are tabulated in Table 1 at
diﬀerent temperatures. Table 1 gives the information that both
KSV and kq values decrease with increasing the temperatures.
In addition to this, kq values for dynamic quenching are
2 × 1010 L·mol−1 ·s−1, but in the present study, they are of the
order 1013 L·mol−1 ·s−1 Hence, these results conﬁrm that the
quenching of BSA by RSN proceeds through static mechanisms.
*is static quenching mechanism of BSA by RSN was further
conﬁrmed by calculating the eﬀective static quenching constant
(Ka) and accessible fraction of ﬂuorophore (fa) in the BSAusing
the following modiﬁed Stern–Volmer equation (4) [25]:
F0
F0 −F � 1fa + 1Kafa[Q]. (4)
Figure 4(b) represents the modiﬁed Stern–Volmer plot,
where the intercept and slope are equal to 1/fa and 1/Kafa,
respectively. Table 1 signiﬁes that the obtained Ka values
decrease with increasing temperature as do KSV values. *is
conﬁrms that RSN quenched the BSA by the static
quenching mechanism.
3.3. Binding Parameters of RSN to BSA. *e aﬃnity of RSN
binding with BSA can be obtained by calculating its binding
constant (Kb) and number of binding sites (n) using the
following equation [26]:
log
F0 −F
F
[ ] � logKb + n log[Q]. (5)
*e plot of log[(F0 −F)/F] versus log[Q] gives
a straight line with slope equal to n and intercept equal to
logKb at diﬀerent temperatures (289, 297, and 305K) as
presented in the Figure 4(c), and their values are tabulated
in Table 2. *e acquired Kb values decrease with increasing
temperatures and of the order 105, and they acknowledge
that the strong binding exists between BSA and RSN and
further conﬁrm the static quenching mechanism. *e n
values are approximately equal to 1 signifying that only one
RSN binds to BSA.
3.4. @ermodynamics and the Forces Involved in BSA-RSN
Complex Stabilization. *e noncovalent interactions between
proteins and small molecules accomplished by determining the
thermodynamic parameters, change in enthalpy (ΔH), and
entropy (ΔS) mainly constitute electrostatic forces, hydrogen
bonds, van derWaals force, and hydrophobic force.ΔH andΔS
are best related by the following van ’t Hoﬀ equation (6) [27]:
lnKb �
−ΔH
RT
+
ΔS
R
, (6)
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Figure 3: Fluorescence emission spectra of BSA (2.5 × 10−6 mol·L−1)
with varying concentrations of RSN (a to k: 0.5 to 5.5 × 10−6 mol·L−1)
with the addition of 0.5 × 10−6 mol·L−1 in each step, and the curve L
represents RSN only (2.5 × 10−6 mol·L−1) at 297K and pH 7.40.
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where R, T, and Kb are the gas constant, temperature, and
calculated binding constant. *e values of ΔH andΔS calculated by using the slope and intercept of the plot
of lnKb against 1/T are shown in inset of Figure 4(c). From
Table 2, it is evident that the obtained negative values of ΔH
and ΔS imitate the van der Waals forces and hydrogen
bonding which are the main binding forces forming the
BSA–RSN complex [28]. *en, these values are utilized to
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Figure 4: (a) Stern–Volmer plot, (b) modiﬁed Stern–Volmer plot, and (c) plot of log[(F0 −F)/F] versus log[Q] (the inset of (c) is van ’t Hoﬀ
plot of the BSA-RSN complex) at diﬀerent temperatures (289, 297, and 305K) at pH 7.40.
Table 1: Stern–Volmer quenching constant, quenching rate constant, and eﬀective static quenching constant for the BSA-RSN complex at
diﬀerent temperatures at pH 7.40.
Compound Temperature (K) KSV (L·mol
−1)× 104 kq (L·mol−1 ·s−1)× 1013 Ka (L·mol−1)× 104
BSA-RSN
289 9.4± 0.02 1.65± 0.01 10.16± 0.05
297 7.7± 0.06 1.35± 0.03 8.86± 0.03
305 6.0± 0.04 1.05± 0.02 7.28± 0.02
KSV is the Stern–Volmer quenching constant; kq is the quenching rate constant; Ka is the eﬀective static quenching constant.
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estimate Gibb’s free energy which is connected by the fol-
lowing equation: ΔG � ΔH−TΔS. (7)
*e summarized ΔG values in Table 2 are negative
and denote the spontaneous and exothermic process.
Since the value of ΔH is less than ΔS, Gibb’s free energy
is typically entropy driven. Hence, the RSN bound to
BSA dominates hydrogen bonding compared to van der
Waals forces.
3.5. Synchronous Fluorescence Analysis. By simultaneously
scanning excitation and emission monochromators in
synchronous ﬂuorescence spectral measurements, the mi-
cro-environmental changes of Tyr and Trp residues could be
analysed. *e change in polarity of Tyr and Trp residues’
microenvironment is achieved by shift in λem: red shift
represents the increase of polarity/decrease of hydropho-
bicity, and blue shift represents decrease of polarity/increase
of hydrophobicity [21].
*e synchronous ﬂuorescence spectra for BSA with
various concentrations of RSN at Δλ� 15 and 60 nm for Tyr
and Trp residues are as shown in Figure 5. *ere is no
spectral shift observed for Tyr (Figure 5(a)), but a charac-
teristic red shift of about 3 nm is observed for Trp (Figure
5(b)). *erefore, it is clear that the microenvironment of Trp
occurs where it is more exposed to polar environment.
3.6. Energy Transfer between BSA and RSN. *e transfer of
excitation energy of various molecules which are already in
excited states without emission of a photon from donor to
acceptor has been used to ﬁnd out ligand-Trp distances in
protein. According to Forster’s nonradiative energy transfer
theory, ﬂuorescence emission spectrum of donor and
UV–vis absorption spectrum of the acceptor should overlap
with their distance which lies between 1 to 10 nm.*e energy
transfer eﬃciency (E) can be written as
Table 2: Binding constants, number of binding sites, and thermodynamic parameters for the interaction of BSA with RSN at diﬀerent
temperatures (pH 7.40).
Compound Temperature (K) Kb (L·mol
−1)× 105 n ΔG (kJ·mol−1) ΔH (kJ·mol−1) ΔS (J·mol−1·K−1)
BSA-RSN
289 3.51± 0.10 1.196 −30.62 −38.83 −28.408
297 1.95± 0.04 1.110 −30.39
305 1.45± 0.07 1.067 −30.16
Kb is the binding constant; n is the number of binding sites; ΔG is the change in Gibb’s free energy; ΔH is change in enthalpy; ΔS is change in entropy.
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Figure 5: Synchronous ﬂuorescence spectra of BSA (2.5 × 10−6 mol·L−1) after interaction with RSN (0 to 5.5 × 10−6 mol·L−1) at 297 K and
pH 7.40: (a) Δλ� 15 nm for Tyr and (b) Δλ� 60 nm for Trp.
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Figure 6: Overlap spectrum between (i) the ﬂuorescence emission
spectrum of BSA and (ii) the UV absorption spectrum of RSN. *e
concentration of BSA and RSN is 3.0 × 10−6 mol·L−1 at 297K and
pH 7.40.
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E �
R60
R60 + r
6 �
F0 −F
F0
, (8)
where R0 is the critical distance when E is 50%, and r is the
mean distance between centers of the BSA and RSN dipoles.
*en, the R0 (cm) can be represented by [23]
R
6
0 � 8.8 × 10
−25
K
2
N
−4
VJ, (9)
where K2 is spatial orientation factor of the dipole, V is
ﬂuorescence quantum yield of the BSA, N is the refractive
index of the medium, and J is overlap integral of the
ﬂuorescence emission spectrum of BSA and absorption
spectrum of the RSN (Figure 6). *e value of J can be
calculated by (10) at λ� 295–425 nm:
J �
∑ Fd(λ)εa(λ)λ
4Δλ[ ]
∑ Fd(λ)Δλ[ ] , (10)
where Fd and εa(λ) are the ﬂuorescence intensity of the BSA
at wavelength λ to λ + Δλ (it has no unit) and the molar
absorption coeﬃcient of the RSN at wavelength is λ. In case
of BSA, K2 � 2/3, N � 1.336, and V � 0.118. *e obtained
results are J � 1.19×10−14 cm3·L·mol−1, E � 70.44%,
r� 0.267 A˚, and R0 � 0.252 A˚. Static quenching of RSN to
BSA was further conﬁrmed from the larger value of r
compared to that of R0. BSA has only two tryptophan
residues, that is, Trp134 and Trp213, mainly responsible for
its ﬂuorescence. So, the FRET tool allowed us for the de-
termination of the distance between the Trp134/Trp-213 and
bound RSN.
3.7. Competitive Binding Measurements. *e determination
of preferable binding site for RSN in BSA was achieved by
performing competitive binding measurements. *e three
binding sites I, II, and III correspond to the subdomains IIA,
IIIA, and IB, respectively. Warfarin, ibuprofen, and digi-
toxin categorically binds to site I, II, and III, respectively
[29]. *e binding constant values calculated for the BSA-
RSN complex in the presence of all the site probes using (5)
(Figure 7(a)) and values are tabulated in Table 3. From
Table 3, it is understood that warfarin and digitoxin have no
eﬀect on BSA-RSN binding, but ibuprofen has a signiﬁcant
amount of eﬀect where obtained binding constant value
varies with a large diﬀerence. Hence, this result suggested
that site II (IIIA) of BSA to undergo major binding with
RSN. Further conﬁrmations about the binding site were well
understood from molecular docking studies.
3.8. Eﬀect ofMetal Ions on BSA-RSNBinding. Many chemical
and biological processes in the human body are mediated via
metal ions which show interaction with proteins. *e ﬂuo-
rescence data of interaction between BSA and RSN in the
presence and absence of Fe2+, Ni2+, Ca2+, Mg2+, and Cd2+ ions
were subjected to binding calculations at 297K using (5). *e
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Figure 7: Plot of log[(F0 −F)/F] versus log[Q] for (a) site markers (digitoxin: A, warfarin: B, and ibuprofen: C) and (b) metal ions (Fe2+: A,
Ca2+: B, Mg2+: C, Ni2+: D, and Cd2+: E) at 297 K and pH 7.40.
Table 3: *e binding constant of the BSA-RSN system in the
presence of site markers and metal ions at 297K (pH 7.40).
System Kb (L·mol
−1)
BSA-RSN 1.95± 0.04×105
BSA-RSN-warfarin 2.0± 0.02×105
BSA-RSN-ibuprofen 2.6± 0.07×104
BSA-RSN-digitoxin 1.97± 0.03×105
BSA-RSN-Fe2+ 1.39± 0.09×103
BSA-RSN-Ni2+ 3.11± 0.02×106
BSA-RSN-Ca2+ 8.77± 0.05×103
BSA-RSN-Mg2+ 4.36± 0.04×103
BSA-RSN-Cd2+ 1.30± 0.08×106
Kb is the binding constant.
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obtained values are charted in Table 3 and their plots are
shown in Figure 7(b). FromTable 3, it can be noticed that Fe2+,
Ca2+, and Mg2+ ions decrease the binding between BSA and
RSN, and Ni2+ and Cd2+ increase the binding between BSA
and RSN. Ni2+ and Cd2+ ions increase the binding aﬃnity of
RSN and BSA due to the formation of metal ion-RSN com-
plexes which in turn interact with the BSA through metal ion
bridge. So, RSN remains interacting with BSA more where it
enhances the eﬀectiveness of RSN [30]. Decreased binding
constants, in the presence of metal ions, may be due to the
competition between ion and RSN and also due to the al-
ternation of conformation of BSA. *erefore, as soon as RSN
enters into the blood, it instantly comes out of it after in-
teraction with BSA in the presence of Fe2+, Ca2+, and Mg2+
ions. So, short time of RSN in blood will not lead to curing of
the required therapeutic eﬀects.*us, more dosage is required.
3.9. Conformational Changes of BSA by FT-IRMeasurements.
*e protein exhibits a number of FT-IR bands, out of which
amide bands give the vibrations of peptide linkage. *ere
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Figure 8: FT-IR spectra at 1700–1500 cm−1 at 297K and pH 7.40. (a) Free BSA after subtraction from buﬀer and (b) bound BSA with RSN
after subtraction from RSN and buﬀer. Concentration of BSA and RSN were kept constant at 3.5 × 10−6 mol·L−1.
Table 4: FT-IR spectral position peaks of free BSA and after interaction with RSN at 297K and pH 7.40.
System
Amide I (cm−1) Amide II (cm−1)
1615–1637 1638–1648 1649–1660 1660–1680 1680–1692 1548
Free BSA 1623± 0.42 1639± 0.95 1649± 0.34 1674± 0.67 1683± 0.41 1541± 0.29
BSA-RSN 1629± 0.84 1643± 0.62 1654± 0.56 1667± 0.85 1690± 0.72 1542± 0.38
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Figure 9: Amide I band (1700–1600 cm−1) of BSA (a) and BSA-RSN system (b) subjected to curve ﬁtting analysis by second derivative
resolution using Gaussian peak function.
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are two amide bands, I and II, which symbolize the
characteristic conformational changes showing vibra-
tions at 1700–1600 cm−1 (C�O stretch) and 1600–1500 cm−1
(combined stretching of C-N and bending of N-H), re-
spectively. Figure 8 represents the FT-IR spectra for BSA in the
presence and absence of RSN, and their peak positions are
Table 5: FT-IR spectral measurements of the secondary structure of BSA during interaction with RSN at 297K and pH 7.40.
System
Secondary structure (%)
β-sheet Random coil α-helix β-turn β-antiparallel
Free BSA 0.39± 0.07 15.73± 0.02 43.86± 0.07 30.59± 0.04 9.42± 0.08
BSA-RSN 1.87± 0.02 36.63± 0.09 41.38± 0.05 19.69± 0.05 0.42± 0.03
(a)
(b)
(c)
Figure 10:*emolecular binding interaction of BSA and RSN for the three binding sites I (IIA), II (IIIA), and III (IB) by molecular docking
studies.
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tabulated in Table 4. *e change in the spectral lines is
observed from Figures 8(a) and 8(b), which reveal that the
formation of a complex between BSA and RSN with con-
formational changes occurred in BSA.
3.10. Inspection of Secondary Structure of BSA. *e amide I
band can be further analyzed for secondary structure of BSA
as the bands are divided into β–sheets, random coil, α-helix,
β-turns, and β-antiparallel, which correspond to the vi-
brations at 1615–1637, 1648–1648, 1649–1660, 1660–1680,
and 1680–1692 cm−1, respectively [31]. Figure 9 shows that
the amide I band is subjected to self-deconvolution by using
curve-ﬁtting procedures with second derivative resolution
enhancement for BSA-RSN interaction, and the changes in
the secondary structure conformation of BSA after in-
teraction with RSN is tabulated in Table 5. *e alteration of
peak positions and amide I band shape gives an idea about
BSA interacting with RSN by secondary structure of mod-
iﬁed BSA.
3.11. Molecular Docking Analysis. *e site marker experi-
ment, thermodynamic calculations, and type of interaction
from the ﬂuorescence study of the BSA-RSN complex were
further conﬁrmed by molecular docking measurements
which give all the major information about interaction
studies. *e ligand binding sites such as site I (IIA), II (IIIA),
and III (IB) of BSA were separately docked with RSN. *e
cluster analysis by root mean square deviation (RMSD)
respectively for 3 binding sites I, II, and III gives cluster
modes (62, 89, and 35) and binding energy −25.03, −30.58,
and −22.47 kJ·mol−1. Based on the lowest binding energy
and largest cluster mode, site II (IIIA) of the BSA after
interaction with RSN undergoes preferable binding com-
pared to other two sites. Figure 10 represents the docked
results of each site where the amino acids surrounding the
RSN could be clearly noticeable. In addition to this, in-
teractions and their distances for all the binding sites are
summarized in Table 6. Moreover, the results of site II (IIIA)
were analyzed further. Table 7 represents the top 5 ideal
energy-ranked results of site II (IIIA) and the values ΔG,
Einter−mol, Evdw+HB+desol, and EElec are the binding free energy;
intermolecular interaction energy; sum of van der Waals
energy, hydrogen bonding energy, and desolvation free
energy; and electrostatic energy. More than 50% of the
amino acid residues in site II surrounded by RSN belong to
polar and ionic. It has been apparent from Table 7,
Evdw+HB+desol is observably more negative than EElec, which
Table 6: Type of interactions, involvement, and their distances between amino acids present in BSA after interaction with RSN for three
binding sites by molecular docking studies.
Binding site
Interactions
Amino acid-RSN atom
Type Distance (A˚)
Site I (IIA)
Conventional hydrogen bond 2.10 ARG:256:HE–N1
1.93 ILE289:O–H7
2.16 ARG217:HE–O7
van der Waals — SER286
— ILE263
— VAL292
Carbon hydrogen bond 3.72 LYS221:CE–O7
Unfavorable positive–positive 5.24 LYS221:NZ–P2
Pi–alkyl 5.03 LEU259:(CG–CD1–D2)–aromatic ring
5.31 ILE289:(CB–CG1–CD1)–aromatic ring
4.95 ARG256: (CB–CG)–aromatic ring
Site II (IIIA)
Conventional hydrogen bond 2.64 ARG409:HE–O7
2.00 ASN:OD1–H9
2.37 ASN390:HD22–O7
2.80 THR448:HG1–N1
2.24 TYR410:HH–O6
1.97 SER488:OG–H7
van der Waals — PHE402
— LEU406
— LEU429
— LEU456
— LEU386
— ARG484
Unfavorable positive–positive 3.33 ARG409:P1–NH2
Pi–alkyl 5.06 LEU452:CG–aromatic ring
Site III (IB)
Pi–sigma 3.93 VAL432:CG1–aromatic ring
Conventional hydrogen bond 1.96 TYR160:HH–O5
van der Waals — LYS136
— PRO117
— GLU140
Pi–sigma 3.96 LEU115:O1–aromatic ring
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signiﬁes that hydrogen bonding and van derWaals forces are
playing a crucial role in the complex formation between RSN
and BSA, and this is in compliance with the thermodynamics
result fetched from theoretical calculations.
3.12. Circular Dichroism (CD) Spectral Analysis. Circular
dichroism (CD) spectral measurements are very eﬀective tool
in studying the conformational modiﬁcations of proteins
upon interaction with small molecules or ligands. CD spectra
of BSA in the absence and presence of RSN (shown in Fig-
ure 11) have two distinctive negative absorption bands at
208 nm (π→ π∗ transition) and 222 nm (n→ π∗ transition)
corresponding to the α-helix of the peptide bond [32]. It could
be noticed from Figure 11 that without shift in the band
maxima, the two negative band intensities of free BSA were
decreased after interaction with RSN, which induces the
changes in the conformation of BSA with the decreasing
α-helix content. *e calculated secondary structures of
BSA before and after interaction with RSN are tabulated in
Table 8.*e content of secondary structures (α-helix, β-strand
antiparallel, and turn) of BSA after the interaction with RSN
was decreased. But, the content of secondary structures
(random coil and β-sheet parallel) of BSA after the interaction
with RSN was increased. *is represents that the polypeptide
chain matrix of BSA was altered after interaction with RSN.
4. Conclusions
In the present work, the interaction between BSA and
RSN were studied thoroughly by multi spectroscopic and
molecular docking methods at physiological pH 7.40.
RSN quenched the HSA by the static quenching mechanism.
*e formed HSA-RSN complex was stabilised by hydrogen
bonding and van der Waals forces. *e obtained binding
constant value for HSA-RSN system is of the order 105
signifying that strong binding exists between HSA and RSN.
For HSA-RSN-Fe2+, HSA-RSN-Ca2+, and HSA-RSN-Mg2+
systems, the binding constants decreased. But for HSA-RSN-
Cd2+ and HSA-RSN-Cd2+ systems, the binding constants
increased. *e subdomain IIIA, that is, site II, was the major
binding site of BSA for RSN. *e distance between
Trp134/Trp213 of BSA and RSN was also achieved. *e
conformational and secondary structure of BSA was mod-
iﬁed after the interaction with RSN. *ese types of studies
are helpful to understand the metabolism, pharmacody-
namics, and pharmacokinetics of RSN.
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